{"id":810713,"date":"2025-02-10T05:48:42","date_gmt":"2025-02-10T10:48:42","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/cassava-sciences-inc-securities-fraud-class-action-lawsuit-pending-contact-the-gross-law-firm-before-february-10-2025-to-discuss-your-rights-sava\/"},"modified":"2025-02-10T05:48:42","modified_gmt":"2025-02-10T10:48:42","slug":"cassava-sciences-inc-securities-fraud-class-action-lawsuit-pending-contact-the-gross-law-firm-before-february-10-2025-to-discuss-your-rights-sava","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/cassava-sciences-inc-securities-fraud-class-action-lawsuit-pending-contact-the-gross-law-firm-before-february-10-2025-to-discuss-your-rights-sava\/","title":{"rendered":"Cassava Sciences, Inc. Securities Fraud Class Action Lawsuit Pending: Contact The Gross Law Firm Before February 10, 2025 to Discuss Your Rights &#8211; SAVA"},"content":{"rendered":"<div class=\"xn-newslines\">\n<p class=\"xn-distributor\">PR Newswire<\/p>\n<\/p><\/div>\n<div class=\"xn-content\">\n<p>\n        <span class=\"legendSpanClass\"><br \/>\n          <span class=\"xn-location\">NEW YORK<\/span><br \/>\n        <\/span>, <span class=\"legendSpanClass\"><span class=\"xn-chron\">Feb. 10, 2025<\/span><\/span> \/PRNewswire\/ &#8212; The Gross Law Firm issues the following notice to shareholders of\u00a0<b>Cassava Sciences, Inc. (NASDAQ: SAVA).<\/b><\/p>\n<div class=\"PRN_ImbeddedAssetReference\" id=\"DivAssetPlaceHolder1\">\n<p>\n          <a href=\"https:\/\/mma.prnewswire.com\/media\/2280333\/The_Gross_Law_Firm_Logo.html\" target=\"_blank\" rel=\"nofollow\"><br \/>\n            <img decoding=\"async\" src=\"https:\/\/mma.prnewswire.com\/media\/2280333\/The_Gross_Law_Firm_Logo.jpg\" title=\"The Gross Law Firm (PRNewsfoto\/The Gross Law Firm)\" alt=\"The Gross Law Firm (PRNewsfoto\/The Gross Law Firm)\" \/><br \/>\n          <\/a>\n        <\/p>\n<\/p><\/div>\n<p>Shareholders who purchased shares of SAVA during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery.<\/p>\n<p class=\"prntac\">CONTACT US HERE:<\/p>\n<p class=\"prntac\">\n        <a href=\"https:\/\/securitiesclasslaw.com\/securities\/cassava-sciences-inc-loss-submission-form-2\/?id=127834&amp;from=4\" rel=\"nofollow\">https:\/\/securitiesclasslaw.com\/securities\/cassava-sciences-inc-loss-submission-form-2\/?id=127834&amp;from=4<\/a>\n      <\/p>\n<p>\n        <b>CLASS PERIOD: <\/b><br \/>\n        <span class=\"xn-chron\">February 7, 2024<\/span> to <span class=\"xn-chron\">November 24, 2024<\/span><\/p>\n<p>\n        <b>ALLEGATIONS: <\/b>According to the complaint, defendants provided investors with material information concerning Cassava&#8217;s leading drug candidate, simufilam. Defendants&#8217; statements included, among other things, clear confidence in simufilam&#8217;s ability to treat Alzheimer&#8217;s Disease. On <span class=\"xn-chron\">November 25, 2024<\/span>, Cassava released topline results for the first of its two ongoing Phase 3 studies on simufilam, the &#8220;ReThink-ALZ&#8221; study. The results indicated that simufilam failed to meet each of the pre-specified primary, secondary, and exploratory endpoints; in sum, simufilam failed to outperform the placebo. Following this news, the price of Cassava&#8217;s common stock declined dramatically. From a closing market price of <span class=\"xn-money\">$26.48<\/span> per share on <span class=\"xn-chron\">November 22, 2024<\/span>, Cassava&#8217;s stock price fell to <span class=\"xn-money\">$4.30<\/span> per share on <span class=\"xn-chron\">November 25, 2024<\/span>, a decline of about 83.76% in the span of just a single day.<\/p>\n<p>\n        <b>DEADLINE: <span class=\"xn-chron\">February 10, 2025<\/span><\/b> Shareholders should not delay in registering for this class action. Register your information here: <a href=\"https:\/\/securitiesclasslaw.com\/securities\/cassava-sciences-inc-loss-submission-form-2\/?id=127834&amp;from=4\" rel=\"nofollow\">https:\/\/securitiesclasslaw.com\/securities\/cassava-sciences-inc-loss-submission-form-2\/?id=127834&amp;from=4<\/a><\/p>\n<p>\n        <b>NEXT STEPS FOR SHAREHOLDERS: <\/b>Once you register as a shareholder who purchased shares of SAVA during the timeframe listed above, you will be enrolled in a portfolio monitoring software to provide you with status updates throughout the lifecycle of the case. The deadline to seek to be a lead plaintiff is <span class=\"xn-chron\">February 10, 2025<\/span>. There is no cost or obligation to you to participate in this case.<\/p>\n<p>\n        <b>WHY GROSS LAW FIRM? <\/b>The Gross Law Firm is a nationally recognized class action law firm, and our mission is to protect the rights of all investors who have suffered as a result of deceit, <span>fraud<\/span>, and illegal business practices. The Gross Law Firm is committed to ensuring that companies adhere to responsible business practices and engage in good corporate citizenship. The firm seeks recovery on behalf of investors who incurred losses when false and\/or misleading statements or the omission of material information by a company lead to artificial inflation of the company&#8217;s stock. Attorney advertising. Prior results do not guarantee similar outcomes.<\/p>\n<p>\n        <b>CONTACT:<\/b><br \/>\n        <br \/>The Gross Law Firm<br \/>15 West 38th Street, 12th floor<br \/><span class=\"xn-location\">New York, NY<\/span>, 10018<br \/>Email: <a href=\"mailto:dg@securitiesclasslaw.com\" rel=\"nofollow\">dg@securitiesclasslaw.com<\/a><br \/>Phone: (646) 453-8903<\/p>\n<p id=\"PURL\">\n        <img loading=\"lazy\" decoding=\"async\" title=\"Cision\" width=\"12\" height=\"12\" alt=\"Cision\" src=\"https:\/\/c212.net\/c\/img\/favicon.png?sn=NY14884&amp;sd=2025-02-10\" \/> View original content to download multimedia:<a id=\"PRNURL\" rel=\"nofollow\" href=\"https:\/\/www.prnewswire.com\/news-releases\/cassava-sciences-inc-securities-fraud-class-action-lawsuit-pending-contact-the-gross-law-firm-before-february-10-2025-to-discuss-your-rights--sava-302371627.html\" target=\"_blank\">https:\/\/www.prnewswire.com\/news-releases\/cassava-sciences-inc-securities-fraud-class-action-lawsuit-pending-contact-the-gross-law-firm-before-february-10-2025-to-discuss-your-rights&#8211;sava-302371627.html<\/a><\/p>\n<p>SOURCE  The Gross Law Firm<\/p>\n<\/p><\/div>\n<p>    <img decoding=\"async\" alt=\"\" src=\"https:\/\/rt.prnewswire.com\/rt.gif?NewsItemId=NY14884&amp;Transmission_Id=202502100545PR_NEWS_USPR_____NY14884&amp;DateId=20250210\" style=\"border:0px;width:1px;height:1px\" \/><\/p>\n","protected":false},"excerpt":{"rendered":"<p>PR Newswire NEW YORK , Feb. 10, 2025 \/PRNewswire\/ &#8212; The Gross Law Firm issues the following notice to shareholders of\u00a0Cassava Sciences, Inc. (NASDAQ: SAVA). Shareholders who purchased shares of SAVA during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery. CONTACT US HERE: https:\/\/securitiesclasslaw.com\/securities\/cassava-sciences-inc-loss-submission-form-2\/?id=127834&amp;from=4 CLASS PERIOD: February 7, 2024 to November 24, 2024 ALLEGATIONS: According to the complaint, defendants provided investors with material information concerning Cassava&#8217;s leading drug candidate, simufilam. Defendants&#8217; statements included, among other things, clear confidence in simufilam&#8217;s ability to treat Alzheimer&#8217;s Disease. On November 25, 2024, Cassava released topline results for the first of its two ongoing Phase &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/cassava-sciences-inc-securities-fraud-class-action-lawsuit-pending-contact-the-gross-law-firm-before-february-10-2025-to-discuss-your-rights-sava\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Cassava Sciences, Inc. Securities Fraud Class Action Lawsuit Pending: Contact The Gross Law Firm Before February 10, 2025 to Discuss Your Rights &#8211; SAVA&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-810713","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.1 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Cassava Sciences, Inc. Securities Fraud Class Action Lawsuit Pending: Contact The Gross Law Firm Before February 10, 2025 to Discuss Your Rights - SAVA - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/cassava-sciences-inc-securities-fraud-class-action-lawsuit-pending-contact-the-gross-law-firm-before-february-10-2025-to-discuss-your-rights-sava\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Cassava Sciences, Inc. Securities Fraud Class Action Lawsuit Pending: Contact The Gross Law Firm Before February 10, 2025 to Discuss Your Rights - SAVA - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"PR Newswire NEW YORK , Feb. 10, 2025 \/PRNewswire\/ &#8212; The Gross Law Firm issues the following notice to shareholders of\u00a0Cassava Sciences, Inc. (NASDAQ: SAVA). Shareholders who purchased shares of SAVA during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery. CONTACT US HERE: https:\/\/securitiesclasslaw.com\/securities\/cassava-sciences-inc-loss-submission-form-2\/?id=127834&amp;from=4 CLASS PERIOD: February 7, 2024 to November 24, 2024 ALLEGATIONS: According to the complaint, defendants provided investors with material information concerning Cassava&#8217;s leading drug candidate, simufilam. Defendants&#8217; statements included, among other things, clear confidence in simufilam&#8217;s ability to treat Alzheimer&#8217;s Disease. On November 25, 2024, Cassava released topline results for the first of its two ongoing Phase &hellip; Continue reading &quot;Cassava Sciences, Inc. Securities Fraud Class Action Lawsuit Pending: Contact The Gross Law Firm Before February 10, 2025 to Discuss Your Rights &#8211; SAVA&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/cassava-sciences-inc-securities-fraud-class-action-lawsuit-pending-contact-the-gross-law-firm-before-february-10-2025-to-discuss-your-rights-sava\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2025-02-10T10:48:42+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mma.prnewswire.com\/media\/2280333\/The_Gross_Law_Firm_Logo.jpg\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cassava-sciences-inc-securities-fraud-class-action-lawsuit-pending-contact-the-gross-law-firm-before-february-10-2025-to-discuss-your-rights-sava\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cassava-sciences-inc-securities-fraud-class-action-lawsuit-pending-contact-the-gross-law-firm-before-february-10-2025-to-discuss-your-rights-sava\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Cassava Sciences, Inc. Securities Fraud Class Action Lawsuit Pending: Contact The Gross Law Firm Before February 10, 2025 to Discuss Your Rights &#8211; SAVA\",\"datePublished\":\"2025-02-10T10:48:42+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cassava-sciences-inc-securities-fraud-class-action-lawsuit-pending-contact-the-gross-law-firm-before-february-10-2025-to-discuss-your-rights-sava\\\/\"},\"wordCount\":446,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cassava-sciences-inc-securities-fraud-class-action-lawsuit-pending-contact-the-gross-law-firm-before-february-10-2025-to-discuss-your-rights-sava\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/2280333\\\/The_Gross_Law_Firm_Logo.jpg\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cassava-sciences-inc-securities-fraud-class-action-lawsuit-pending-contact-the-gross-law-firm-before-february-10-2025-to-discuss-your-rights-sava\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cassava-sciences-inc-securities-fraud-class-action-lawsuit-pending-contact-the-gross-law-firm-before-february-10-2025-to-discuss-your-rights-sava\\\/\",\"name\":\"Cassava Sciences, Inc. Securities Fraud Class Action Lawsuit Pending: Contact The Gross Law Firm Before February 10, 2025 to Discuss Your Rights - SAVA - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cassava-sciences-inc-securities-fraud-class-action-lawsuit-pending-contact-the-gross-law-firm-before-february-10-2025-to-discuss-your-rights-sava\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cassava-sciences-inc-securities-fraud-class-action-lawsuit-pending-contact-the-gross-law-firm-before-february-10-2025-to-discuss-your-rights-sava\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/2280333\\\/The_Gross_Law_Firm_Logo.jpg\",\"datePublished\":\"2025-02-10T10:48:42+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cassava-sciences-inc-securities-fraud-class-action-lawsuit-pending-contact-the-gross-law-firm-before-february-10-2025-to-discuss-your-rights-sava\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cassava-sciences-inc-securities-fraud-class-action-lawsuit-pending-contact-the-gross-law-firm-before-february-10-2025-to-discuss-your-rights-sava\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cassava-sciences-inc-securities-fraud-class-action-lawsuit-pending-contact-the-gross-law-firm-before-february-10-2025-to-discuss-your-rights-sava\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/2280333\\\/The_Gross_Law_Firm_Logo.jpg\",\"contentUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/2280333\\\/The_Gross_Law_Firm_Logo.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cassava-sciences-inc-securities-fraud-class-action-lawsuit-pending-contact-the-gross-law-firm-before-february-10-2025-to-discuss-your-rights-sava\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Cassava Sciences, Inc. Securities Fraud Class Action Lawsuit Pending: Contact The Gross Law Firm Before February 10, 2025 to Discuss Your Rights &#8211; SAVA\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Cassava Sciences, Inc. Securities Fraud Class Action Lawsuit Pending: Contact The Gross Law Firm Before February 10, 2025 to Discuss Your Rights - SAVA - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/cassava-sciences-inc-securities-fraud-class-action-lawsuit-pending-contact-the-gross-law-firm-before-february-10-2025-to-discuss-your-rights-sava\/","og_locale":"en_US","og_type":"article","og_title":"Cassava Sciences, Inc. Securities Fraud Class Action Lawsuit Pending: Contact The Gross Law Firm Before February 10, 2025 to Discuss Your Rights - SAVA - Market Newsdesk","og_description":"PR Newswire NEW YORK , Feb. 10, 2025 \/PRNewswire\/ &#8212; The Gross Law Firm issues the following notice to shareholders of\u00a0Cassava Sciences, Inc. (NASDAQ: SAVA). Shareholders who purchased shares of SAVA during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery. CONTACT US HERE: https:\/\/securitiesclasslaw.com\/securities\/cassava-sciences-inc-loss-submission-form-2\/?id=127834&amp;from=4 CLASS PERIOD: February 7, 2024 to November 24, 2024 ALLEGATIONS: According to the complaint, defendants provided investors with material information concerning Cassava&#8217;s leading drug candidate, simufilam. Defendants&#8217; statements included, among other things, clear confidence in simufilam&#8217;s ability to treat Alzheimer&#8217;s Disease. On November 25, 2024, Cassava released topline results for the first of its two ongoing Phase &hellip; Continue reading \"Cassava Sciences, Inc. Securities Fraud Class Action Lawsuit Pending: Contact The Gross Law Firm Before February 10, 2025 to Discuss Your Rights &#8211; SAVA\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/cassava-sciences-inc-securities-fraud-class-action-lawsuit-pending-contact-the-gross-law-firm-before-february-10-2025-to-discuss-your-rights-sava\/","og_site_name":"Market Newsdesk","article_published_time":"2025-02-10T10:48:42+00:00","og_image":[{"url":"https:\/\/mma.prnewswire.com\/media\/2280333\/The_Gross_Law_Firm_Logo.jpg","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cassava-sciences-inc-securities-fraud-class-action-lawsuit-pending-contact-the-gross-law-firm-before-february-10-2025-to-discuss-your-rights-sava\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cassava-sciences-inc-securities-fraud-class-action-lawsuit-pending-contact-the-gross-law-firm-before-february-10-2025-to-discuss-your-rights-sava\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Cassava Sciences, Inc. Securities Fraud Class Action Lawsuit Pending: Contact The Gross Law Firm Before February 10, 2025 to Discuss Your Rights &#8211; SAVA","datePublished":"2025-02-10T10:48:42+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cassava-sciences-inc-securities-fraud-class-action-lawsuit-pending-contact-the-gross-law-firm-before-february-10-2025-to-discuss-your-rights-sava\/"},"wordCount":446,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cassava-sciences-inc-securities-fraud-class-action-lawsuit-pending-contact-the-gross-law-firm-before-february-10-2025-to-discuss-your-rights-sava\/#primaryimage"},"thumbnailUrl":"https:\/\/mma.prnewswire.com\/media\/2280333\/The_Gross_Law_Firm_Logo.jpg","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cassava-sciences-inc-securities-fraud-class-action-lawsuit-pending-contact-the-gross-law-firm-before-february-10-2025-to-discuss-your-rights-sava\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/cassava-sciences-inc-securities-fraud-class-action-lawsuit-pending-contact-the-gross-law-firm-before-february-10-2025-to-discuss-your-rights-sava\/","name":"Cassava Sciences, Inc. Securities Fraud Class Action Lawsuit Pending: Contact The Gross Law Firm Before February 10, 2025 to Discuss Your Rights - SAVA - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cassava-sciences-inc-securities-fraud-class-action-lawsuit-pending-contact-the-gross-law-firm-before-february-10-2025-to-discuss-your-rights-sava\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cassava-sciences-inc-securities-fraud-class-action-lawsuit-pending-contact-the-gross-law-firm-before-february-10-2025-to-discuss-your-rights-sava\/#primaryimage"},"thumbnailUrl":"https:\/\/mma.prnewswire.com\/media\/2280333\/The_Gross_Law_Firm_Logo.jpg","datePublished":"2025-02-10T10:48:42+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cassava-sciences-inc-securities-fraud-class-action-lawsuit-pending-contact-the-gross-law-firm-before-february-10-2025-to-discuss-your-rights-sava\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/cassava-sciences-inc-securities-fraud-class-action-lawsuit-pending-contact-the-gross-law-firm-before-february-10-2025-to-discuss-your-rights-sava\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cassava-sciences-inc-securities-fraud-class-action-lawsuit-pending-contact-the-gross-law-firm-before-february-10-2025-to-discuss-your-rights-sava\/#primaryimage","url":"https:\/\/mma.prnewswire.com\/media\/2280333\/The_Gross_Law_Firm_Logo.jpg","contentUrl":"https:\/\/mma.prnewswire.com\/media\/2280333\/The_Gross_Law_Firm_Logo.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cassava-sciences-inc-securities-fraud-class-action-lawsuit-pending-contact-the-gross-law-firm-before-february-10-2025-to-discuss-your-rights-sava\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Cassava Sciences, Inc. Securities Fraud Class Action Lawsuit Pending: Contact The Gross Law Firm Before February 10, 2025 to Discuss Your Rights &#8211; SAVA"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/810713","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=810713"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/810713\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=810713"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=810713"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=810713"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}